Fri May 23, 2014 3:09am EDT
* GSK announces regulatory submission for Umeclidinium Monotherapy for COPD in Japan
* Regulatory filings in other countries will take place throughout 2014 and onwards Further company coverage:
* GSK announces regulatory submission for Umeclidinium Monotherapy for COPD in Japan
* Regulatory filings in other countries will take place throughout 2014 and onwards Further company coverage:
via Smart Health Shop Forum http://ift.tt/1r0mLnA
No comments:
Post a Comment